<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p125" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_125{left:130px;bottom:1195px;letter-spacing:0.21px;}
#t2_125{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_125{left:128px;bottom:1095px;letter-spacing:-0.24px;}
#t4_125{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_125{left:238px;bottom:1072px;letter-spacing:-0.01px;}
#t6_125{left:238px;bottom:1052px;letter-spacing:-0.01px;}
#t7_125{left:238px;bottom:1033px;letter-spacing:-0.01px;}
#t8_125{left:238px;bottom:1013px;letter-spacing:-0.01px;}
#t9_125{left:238px;bottom:994px;letter-spacing:-0.01px;}
#ta_125{left:238px;bottom:975px;letter-spacing:-0.01px;}
#tb_125{left:238px;bottom:955px;letter-spacing:-0.01px;}
#tc_125{left:655px;bottom:955px;letter-spacing:-0.01px;}
#td_125{left:238px;bottom:936px;letter-spacing:-0.01px;}
#te_125{left:238px;bottom:916px;letter-spacing:-0.01px;}
#tf_125{left:238px;bottom:897px;letter-spacing:-0.01px;}
#tg_125{left:238px;bottom:877px;letter-spacing:-0.01px;}
#th_125{left:318px;bottom:877px;letter-spacing:-0.01px;}
#ti_125{left:354px;bottom:877px;}
#tj_125{left:365px;bottom:877px;letter-spacing:-0.01px;}
#tk_125{left:238px;bottom:858px;letter-spacing:-0.01px;}
#tl_125{left:238px;bottom:839px;letter-spacing:-0.01px;}
#tm_125{left:238px;bottom:819px;letter-spacing:-0.01px;}
#tn_125{left:238px;bottom:800px;letter-spacing:-0.01px;}
#to_125{left:266px;bottom:726px;letter-spacing:-0.01px;}
#tp_125{left:293px;bottom:710px;letter-spacing:-0.01px;}
#tq_125{left:266px;bottom:668px;letter-spacing:-0.01px;}
#tr_125{left:293px;bottom:652px;letter-spacing:-0.01px;}
#ts_125{left:248px;bottom:613px;letter-spacing:-0.01px;}
#tt_125{left:299px;bottom:613px;letter-spacing:-0.01px;}
#tu_125{left:248px;bottom:569px;letter-spacing:0.27px;}
#tv_125{left:323px;bottom:569px;letter-spacing:0.2px;}
#tw_125{left:248px;bottom:545px;letter-spacing:0.23px;}
#tx_125{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_125{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_125{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_125{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_125{font-size:26px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_125{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_125{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.s6_125{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#F78C00;}
.s7_125{font-size:13px;font-family:NotoSans-Regular_7j-;color:#F78C00;}
.s8_125{font-size:13px;font-family:NotoSans-Bold_7ka;color:#000;}
.s9_125{font-size:11px;font-family:NotoSans-Bold_7ka;color:#000;}
.sa_125{font-size:11px;font-family:NotoSans-Regular_7j-_1;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts125" type="text/css" >

@font-face {
	font-family: NotoSans-Bold_7ka;
	src: url("fonts/NotoSans-Bold_7ka.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-_1;
	src: url("fonts/NotoSans-Regular_7j-_1.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg125Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg125" style="-webkit-user-select: none;"><object width="908" height="1286" data="125/125.svg" type="image/svg+xml" id="pdf125" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_125" class="t s0_125">10. Quality indicators </span><span id="t2_125" class="t s1_125">125 </span>
<span id="t3_125" class="t s2_125">10. </span><span id="t4_125" class="t s3_125">Quality indicators </span>
<span id="t5_125" class="t s4_125">Quality indicators (QI) are measurement variables that are used to assess the quality of the </span>
<span id="t6_125" class="t s4_125">underlying structures, processes or results [433]. Quality indicators are an important </span>
<span id="t7_125" class="t s4_125">instrument of quality management. The aim of their use is to continuously improve care by </span>
<span id="t8_125" class="t s4_125">presenting the results of care, critically reflecting on them and, if necessary, improving them. </span>
<span id="t9_125" class="t s4_125">The present selection of quality indicators was created according to the methodology of the </span>
<span id="ta_125" class="t s4_125">oncology guideline program [434]. The basis for the creation of the quality indicators were all </span>
<span id="tb_125" class="t s4_125">strong recommendations (strength of recommendation A, “should”) </span><span id="tc_125" class="t s5_125">of the guideline, as well as </span>
<span id="td_125" class="t s5_125">a search for existing national and international QIs. A working group “AG Quality Indicators” </span>
<span id="te_125" class="t s5_125">was formed for the process. The exact procedure is set out in the guideline report. After a </span>
<span id="tf_125" class="t s5_125">face-to-face meeting and a telephone conference of this working group, six indicators were </span>
<span id="tg_125" class="t s5_125">adopted (see</span><span id="th_125" class="t s6_125">Table </span><span id="ti_125" class="t s7_125">9 </span><span id="tj_125" class="t s5_125">). In addition to the derived QIs, the QI working group has identified the </span>
<span id="tk_125" class="t s5_125">time between surgery and the end of radiotherapy as an area with potential for improvement. </span>
<span id="tl_125" class="t s5_125">Since the underlying recommendation (No. 69) cannot be used as a "should" recommendation </span>
<span id="tm_125" class="t s5_125">according to the methodology of the guideline program for the derivation of the QIs, the QI </span>
<span id="tn_125" class="t s5_125">working group suggests that </span>
<span id="to_125" class="t s5_125">1. An evaluation should be carried out using the cancer registers, in which the period </span>
<span id="tp_125" class="t s5_125">from surgery to the end of radiotherapy is presented, if possible nationwide. </span>
<span id="tq_125" class="t s5_125">2. a corresponding key figure is submitted to the certification committee of the </span>
<span id="tr_125" class="t s5_125">KHT centres: </span>
<span id="ts_125" class="t s8_125">counter</span><span id="tt_125" class="t s5_125">: Number of patients who completed radiotherapy within 77 days after surgery </span>
<span id="tu_125" class="t s9_125">denominator</span><span id="tv_125" class="t sa_125">: All patients with initial diagnosis of laryngeal carcinoma and </span>
<span id="tw_125" class="t sa_125">postoperative radiotherapy </span>
<span id="tx_125" class="t sa_125">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
